Clinical Trials Browser

Interventional × Pleural Neoplasms × Other solid neoplasm × Clear all

Mesothelioma, Malignant, Pulmonary Atelectasis, Hemothorax, Lung Diseases, Pericardial Effusion, Pleural Diseases, Pleural Neoplasms, Pneumothorax, Pleural Effusion, Malignant, Empyema, Pleural, Respiratory Aspiration

NCT01776385 2018-07-23

The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma

Phase NA Completed

9 enrolled

Head & NeckOther solid neoplasmThoracic

Mesothelioma, Parathyroid Neoplasms, Pleural Neoplasms, Pneumothorax, Thyroid Neoplasms

NCT00154388 2016-11-18

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Phase 2 Completed

185 enrolled

BreastDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Malignant mesenchymal tumor, Adenocarcinoma, Brenner Tumor, Carcinoma, Renal Cell, Chondrosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Fibroma, Hemangiopericytoma, Hemangiosarcoma, Leiomyosarcoma, Leukemia, Mast-Cell, Liposarcoma, Mastocytosis, Melanoma, Mesothelioma, Multiple Myeloma, Pleural Neoplasms, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Thymoma, Hypereosinophilic Syndrome, Sarcoma, Endometrial Stromal, Dermatofibrosarcoma, Rhabdomyosarcoma, Embryonal, Seminoma, Carcinoma, Ductal, Breast, Neurofibrosarcoma, Primary Myelofibrosis, Small Cell Lung Carcinoma

Clinical Trials

VATS

The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases